IRCT20200418047126N1
Recruiting
Phase 3
Evaluation of the therapeutic effect of colchicine plus chloroquine in comparison with chloroquine in patients with COVID-19
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Pulmonary infection of COVD19.
- Sponsor
- Ardabil University of Medical Sciences
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Positive PCR for COVID19
Exclusion Criteria
- •Sensitivity of patients to any medication that is in the regimen
- •Renal failure
- •Heart disease
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Effect of Colchicine on aphthous ulceration.Aphthous.Recurrent oral aphthaeK12.0IRCT20160920029889N4Mazandaran University of Medical Sciences10
Recruiting
Phase 3
Effect of Colchicine in patient presenting with non ST-elevation myocardial infarctioIRCT20190601043780N1Mashhad University of Medical Sciences140
Completed
Phase 2
Colchicine in combination with infliximb compared with infliximb in the treatment of patients with Covidian 19COVID-19.COVID-19, virus identifiedU07.1IRCT20200325046854N2Iran University of Medical Sciences70
Active, not recruiting
Phase 1
Evaluation of the efficacy of colchicine with and without betamethasone mouthwash in the management of recurrent aphthous stomatitis - ART1Recurrent aphthous stomatitis (RAS)EUCTR2006-003327-36-GBGuy's & St Thomas' NHS Foundation Trust136
Recruiting
Phase 2
Evaluation of the efficacy and safety of colchicine in the prevention for post-CABG atrial fibrillatioAtrial Fibrillation.Unspecified atrial fibrillationI48.91IRCT20200328046886N6Mazandaran University of Medical Sciences172